BZAM Reports Rising Revenue, But Also A Short Runway On Cash

May 1, 2023 · Green Market Report

BZAM says it’s a going concern.

Late after the markets closed on Friday, BZAM Ltd. (formerly The Green Organic Dutchman) (CSE: BZAM) (OTC: BZAMF) released its financial results for the fourth quarter ending and year ending December 31, 2022 in Canadian dollars. In the fourth quarter, BZAM reported gross revenue increased 100% to $24 million over last year’s $12 million for the same time period. BZAM said the increase in revenue was driven by the introduction of new products to the market, as well as increased distribution and demand for existing SKUs, with the BZAM Transaction contributing $8.9 million in gross revenue and $5.7 million in net revenue since the closing of the BZAM Transaction.

The net loss for the quarter was $9.6 million, which was higher than last year’s net loss of $6.2 million for the same time period. The company said the increased loss was primarily due to increased loss from operations as well as the impairment loss of $22 million in the quarter. This was a combination of impairments on HemPoland and the Puslinch facility, plus the impairment loss of $12 million arising from the potential sale of the Galaxie assets.

For the full year, BZAM reported revenue of $68 million versus $39 million for 2021. The net loss for the year was trimmed to $36 million in 2022 from $42 million in 2021. The loss from operations was $35 million for the year.

“In November 2022, the company completed a transformational merger and established BZAM as a top player in Canada. This enhanced scale gives us a solid platform for sustained growth on the revenue side, both in Canada and abroad, while allowing us to take advantage of synergies and eliminate duplicative costs across the newly combined entity” commented Matt Milich, CEO. “The integration has been going smoothly and with approximately $24 million in net revenue booked in the first quarter of 2023, representing quarterly growth of nearly 40%, we continue to pursue our goals of positive adjusted EBITDA and free cash flow in 2023.”

Going Concern

Despite the improvement in revenue, BZAM still stated that it was filing its earnings as a going concern. The company’s cash and cash equivalents at the end of the year were just $4.6 million. The company ended the year with a positive working capital of $45 million and an accumulated deficit of $514 million. It wrote, “The Company has insufficient cash on hand to fund its planned operations. The Company’s ability to continue as a going concern is dependent upon its ability to generate sufficient revenues and positive cash flows from its operating activities and/or obtain sufficient funding to meet its obligations, neither of which is guaranteed to occur.”

The company also announced board changes with Wendy Kaufman and Sherry Tross getting added to the board of directors, effective as of April 28, 2023. Jacques Desserault and Louis Sterling have stepped down as directors of the Board. (Full Story)

In category:International
Next Post

PharmaCielo Sees Sales Jump In The Fourth Quarter

PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia’s premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., released its financial results for the fourth quarter and year ended December 31, 2022. The company reported $1.5 million…
Previous Post

Thailand: Southeast Asia's 'weed wonderland'

A new symbol has appeared in the kaleidoscopic jumble of neon signs that light up Sukhumvit Road, Bangkok's most international street. The sudden ubiquity of the five-pointed marijuana leaf, in lurid green, announces the spectacular boom there has been in…
Random Post

New York’s Retail Bottleneck Could Fuel a $7.2B Illicit Market

Illicit operators in New York are expected to capture $7.2 billion in untaxed revenue by 2030, according to a new report prepared by MPG Consulting for Acreage Holdings. In the New York Illicit Cannabis Market Absorption Analysis, MPG’s consultants outline the…
Random Post

New York Sued Over Social Equity Cannabis Retail Licensing Plan

A group that includes some of New York’s medical cannabis companies is suing the state over its plan to issue adult-use retail cannabis licenses to social equity applicants before opening applications to all businesses, reports. The complaint alleges unconstitutional overreach and…
Random Post

Holy Smokes

Chef Jake Cohen’s professional culinary journey has been ruled by two constants: his love of cooking Jewish food and his love of cannabis. The chef, social media star, best-selling cookbook author and food-scene darling has been an out-and-proud stoner from…
Random Post

Hawaii Lawmakers Announce Marijuana Legalization Push For 2023, With Newly Seated Pro-Reform Governor

Hawaii advocates are feeling confident about the prospects of advancing marijuana legalization in the new session, with an activist coalition holding a press conference on Wednesday alongside state lawmakers to lay out the path forward for reform. There’s renewed reason…